Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

STO/PILA stock hub

STO/PILA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/PILAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

81.5M

Nasdaq Stockholm

Market data

Price

Recent price action with selectable time range.

STO/PILASTO/PILA

—

Loading chart…

In the news

Latest news · STO/PILA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-170.8

P25 n/aP50 n/aP75 n/a

ROIC-50.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/PILA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

154

Groups with data

Currency

SEK

Showing 154 of 154 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	1
Employees Change	-2%
Employees Change Percent	-66.67
Enterprise value	SEK 65.6M
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Biotechnology
Isin	SE0015988274
Last refreshed	2026-05-10
Market cap	SEK 81.5M
Price	SEK 1.79
Price currency	SEK
Rev Per Employee	1,126,739x
Sector	Healthcare
Sic	2834
Symbol	sto/PILA
Website	https://pilapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-20.85%
EV Earnings	-3.86x
EV/Sales	58.26x
P/B ratio	5.57x
P/S ratio	72.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	SEK -6M
Net Income	SEK -17M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-1,509%
Profit Per Employee	SEK -17M
ROA	-44.75
Roa5y	-42.46
ROCE	-54.86
ROE	-170.8
Roe5y	-143.7
ROIC	-50.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-38.15%
Cagr3y	-14.14%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	42.65x
Revenue Growth Q	157.97x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	2.41x
Revenue Growth5 Y	-8.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.1
Assets	SEK 16.2M
Cash	SEK 15.9M
Current Assets	SEK 16.2M
Current Liabilities	SEK 1.6M
Equity	SEK 14.6M
Interest Coverage	-2,289.5
Liabilities	SEK 1.6M
Long Term Assets	SEK 65,030
Long Term Liabilities	SEK 0
Net Cash	SEK 15.9M
Net Cash By Market Cap	SEK 19.5
Net Cash Growth	224.9%
Net Debt Equity	SEK -1.09
Tangible Book Value	SEK 14.6M
Tangible Book Value Per Share	SEK 0.35
WACC	2.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.27
Net Working Capital	SEK -1.3M
Quick ratio	10.2
Working Capital	SEK 14.6M
Working Capital Turnover	SEK 0.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-35.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-38.13%
200-day SMA	2
3Y total return	-36.7%
50-day SMA	1.51
50-day SMA vs 200-day SMA	50under200
All Time High	12.9
All Time High Change	-86.16%
All Time High Date	2021-08-06
All Time Low	0.99
All Time Low Change	79.94%
All Time Low Date	2023-10-20
ATR	0.24
Beta	-0.32
Beta1y	-0.14
Beta2y	0.57
Ch YTD	-13.35
High	1.9
High52	3.93
High52 Date	2025-07-15
High52ch	-54.58%
Low	1.72
Low52	1.02
Low52 Date	2026-01-26
Low52ch	74.32%
Ma50ch	18.53%
Price vs 200-day SMA	-10.93%
RSI	55.49
RSI Monthly	41.62
RSI Weekly	49.06
Sharpe ratio	-0.07x
Sortino ratio	-0.04
Total Return	-35.92%
Tr YTD	-13.35
Tr1m	-0.83%
Tr1w	0.56%
Tr3m	48.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -8M
Operating margin	-713

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	29,946,594%
Shares Insiders	19.47%
Shares Institutions	16.71%
Shares Out	45,682,121
Shares Qo Q	55.14%
Shares Yo Y	35.92%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	114,100x
Bv Per Share	0.35
Ch1m	-0.83
Ch1w	0.56
Ch1y	-38.13
Ch3m	48.01
Ch3y	-36.7
Ch6m	-21.54
Change	-0.28%
Change From Open	-5.05
Close	1.79
Days Gap	5.03
Depreciation Amortization	1,077,444
Dollar Volume	83,552.3
Earnings Date	2026-04-21
EBIT	SEK -8M
EBITDA	SEK -7M
EPS	SEK -0.49
F Score	3
Financing CF	17,635,941
Fiscal Year End	December
Founded	2,014
Is Primary Listing	1
Last Earnings Date	2026-04-21
Last Report Date	2025-12-31
Ma150	1.84
Ma150ch	-3.04%
Ma20	1.73
Ma20ch	3.3%
Net CF	11,004,496
Next Earnings Date	2026-08-27
Open	1.88
Position In Range	37.84
Price Date	2026-05-08
Ptbv Ratio	5.57
Relative Volume	0.41x
Revenue	1,126,739x
Tr6m	-21.54%
Volume	46,808
Z Score	26.81

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/PILA pay a dividend?

Capital-return profile for this ticker.

Performance

STO/PILA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/PILA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+16.7%

Share of float held by funds and institutions

Insider ownership

+19.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+35.9%

Negative means the company is buying back shares.

Technical

STO/PILA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.5

Neutral momentum band

Price vs 200-day MA

-10.9%

50/200-day relationship not available

Beta (5Y)

-0.32

Less volatile than the market

Sharpe ratio

-0.07

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/PILA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/PILA stock rating?

sto/PILA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/PILA analysis?

The full report lives at /stocks/sto/PILA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/PILA?

The latest report frames sto/PILA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/PILA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.